MTVA CIK: 1638287

MetaVia Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.1
FY22:
−11.7
FY23:
−10.8
FY24:
−24.7
FY25:
−15.7
Change from FY21 to FY25
millions USD
FY21:
−0.59
FY22:
0.01
FY23:
−0.05
FY24:
−0.01
FY25:
0.00
Change from FY21 to FY25
millions USD
FY21:
22.0
FY22:
28.7
FY23:
−0.08
FY24:
18.3
FY25:
9.96
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.1
FY22:
–
FY23:
−10.8
FY24:
−24.7
FY25:
−15.7

All amounts in millions USD Data source:SEC EDGAR